The First Trimester Combined Screening Test in the Indian Population: Insights from a Cohort of 27,647 Pregnancies
Tóm tắt
To analyse the distribution and determinants of the first trimester screening risk for the detection of trisomy 21 in the population in and around Chennai, a south Indian metropolitan city. A cross-sectional analysis of 27,647 singleton pregnancies that underwent the first trimester combined screening test (FTS) was carried out. For the screen positive cases, karyotype reports or postnatal phenotype outcome were available. The distribution of the various components of risk assessment in the screen positive cases and screen negative cases formed the main outcome measures. Of the 27,647 cases, 4.6% (1270) of cases had unossified nasal bone; 1.8% (499/27,647) had risk more than 1:250 (screen positive). Fifteen (3.2%) of the screen positive cases had confirmed Down syndrome while 46 had termination of pregnancy and 8 had fetal loss. With the current screening protocol, the screen positive rate and the odds of being affected given a positive result (OAPR) for a threshold of 1:250 are 1.8% and 1 in 25 respectively.
Tài liệu tham khảo
SRS Statistical Report -Detailed tables-2014.pdf [Internet]. Available at: http://www.censusindia.gov.in/vital_statistics/SRS_Report_2014/9.%20SRS%20Statistical%20Report%20-Detailed%20tables-2014.pdf. Assessed 15 Sep 2016.
The World Factbook — Central Intelligence Agency [Internet]. Available at: https://www.cia.gov/library/publications/resources/the-world-factbook/geos/in.html. Assessed 15 Sep 2016.
Verma IC, Bijarnia S. The burden of genetic disorders in India and a framework for community control. Community Genet. 2002;5:192–6.
Sharma R. Birth defects in India: hidden truth, need for urgent attention. Indian J Hum Genet. 2013;19:125–9.
Thilaganathan B, Khare M, Williams B, Wathen NC. Influence of ethnic origin on nuchal translucency screening for Down’s syndrome. Ultrasound Obstet Gynecol. 1998;12:112–4.
Jou H-J, Wu S-C, Li T-C, Hsu H-C, Tzeng C-Y, Hsieh F-J. Relationship between fetal nuchal translucency and crown-rump length in an Asian population. Ultrasound Obstet Gynecol. 2001;17:111–4.
Spencer K, Heath V, El-Sheikhah A, Ong CYT, Nicolaides KH. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn. 2005;25:365–9.
Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K. Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study. Lancet. 2001;358:1665–7.
Alfirevic Z, Neilson JP. Antenatal screening for Down’s syndrome. BMJ. 2004;329:811–2.
Cowans NJ, Suonpaa M, Kouru H, Wright D, Spencer K. Evaluation of a dried blood spot assay to measure prenatal screening markers pregnancy-associated plasma protein a and free β-subunit of human chorionic gonadotropin. Clin Chem. 2013;59:968–75.
Cowans NJ, Stamatopoulou A, Liitti P, Suonpaa M, Spencer K. The stability of free-β human chorionic gonadotrophin and pregnancy-associated plasma protein-A in first trimester dried blood spots. Prenat Diagn. 2011;31:293–8.
Pennings JLA, Siljee JE, Imholz S, et al. Comparison of different blood collection, sample matrix, and immunoassay methods in a prenatal screening setting. Dis Mark. 2014;2014:Article ID 509821.
Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. SURUSS in perspective. Semin Perinatol. 2005;29:225–35.
Baxi A, Kaushal M. Awareness and acceptability in Indian women of triple test screening for down. Internet J Gynecol Obstet [Internet]. 2007;9. Available at: http://ispub.com/IJGO/9/2/8714. Assessed 22 Nov 2016.
The 11–13 weeks scan | Education | The Fetal Medicine Foundation [Internet]. Available at: https://fetalmedicine.org/education/the-11-13-weeks-scan. Assessed 18 Nov 2016.
Snijders RJM, Sundberg K, Holzgreve W, Henry G, Nicolaides KH. Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol. 1999;13:167–70.